BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26649808)

  • 1. Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography.
    Flavell RR; Truillet C; Regan MK; Ganguly T; Blecha JE; Kurhanewicz J; VanBrocklin HF; Keshari KR; Chang CJ; Evans MJ; Wilson DM
    Bioconjug Chem; 2016 Jan; 27(1):170-8. PubMed ID: 26649808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
    Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C
    Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of an N-[
    Wu Z; Ma J; Brownell AL; Wang H; Li C; Meng X; Yuan L; Liu H; Li S; Xie J
    Nucl Med Biol; 2018 Nov; 66():40-48. PubMed ID: 30248568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
    Nielsen CH; Jensen MM; Kristensen LK; Dahlman A; Fröhlich C; Jacobsen HJ; Poulsen TT; Lantto J; Horak ID; Kragh M; Kjaer A
    Oncotarget; 2015 Nov; 6(35):37486-99. PubMed ID: 26460961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-Fluorodeoxyglucamines: Reductive amination of hydrophilic (18)F-fluoro-2-deoxyglucose with lipophilic amines for the development of potential PET imaging agents.
    Baranwal A; Mukherjee J
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2902-6. PubMed ID: 26048782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of positron emission tomography/fluorescence dual imaging probes for targeting facilitated glucose transporter 1 (GLUT1).
    Yuen R; Wagner M; Richter S; Dufour J; Wuest M; West FG; Wuest F
    Org Biomol Chem; 2021 Apr; 19(14):3241-3254. PubMed ID: 33885579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
    Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
    Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of [(18)F]F-GAZ, a novel oxygen-mimetic azomycin-glucose conjugate, for imaging hypoxic tumor.
    Wuest M; Kumar P; Wang M; Yang J; Jans HS; Wiebe LI
    Cancer Biother Radiopharm; 2012 Oct; 27(8):473-80. PubMed ID: 22746267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
    McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N
    Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
    Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
    J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
    Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
    Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel synthesis and initial preclinical evaluation of (18)F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent.
    AlJammaz I; Al-Otaibi B; AlHindas H; Okarvi SM
    Nucl Med Biol; 2015 Oct; 42(10):804-8. PubMed ID: 26160144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H
    Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for direct site-specific radiolabeling of peptides using [18F]FDG.
    Namavari M; Cheng Z; Zhang R; De A; Levi J; Hoerner JK; Yaghoubi SS; Syud FA; Gambhir SS
    Bioconjug Chem; 2009 Mar; 20(3):432-6. PubMed ID: 19226160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.
    Barthel H; Cleij MC; Collingridge DR; Hutchinson OC; Osman S; He Q; Luthra SK; Brady F; Price PM; Aboagye EO
    Cancer Res; 2003 Jul; 63(13):3791-8. PubMed ID: 12839975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET.
    Lu L; Jiang L; Guan H; Gao Y; Lu H
    Hell J Nucl Med; 2012; 15(3):206-9. PubMed ID: 23106052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
    Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
    Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy response monitoring of the early effects of a new BRAF inhibitor on melanoma xenograft in mice: evaluation of (18) F-FDG-PET and (18) F-FLT-PET.
    Geven EJ; Evers S; Nayak TK; Bergström M; Su F; Gerrits D; Franssen GM; Boerman OC
    Contrast Media Mol Imaging; 2015; 10(3):203-10. PubMed ID: 25204436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.